SpiroHome offers a personal ultrasonic spirometer that enables patients with asthma, COPD, and cystic fibrosis to conduct lung function tests at home and track their lung health trends through a mobile app. The SpiroCloud platform aggregates and analyzes data from connected devices, facilitating remote management of respiratory conditions for patients and healthcare providers.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with chronic respiratory conditions like asthma, COPD, and cystic fibrosis often require frequent lung function monitoring, but traditional clinic-based spirometry can be inconvenient and limit the frequency of testing. This can lead to delays in detecting changes in lung function and adjusting treatment plans.
Solution
SpiroHome offers a personal ultrasonic spirometer that allows patients to perform lung function tests at home. The device connects to a mobile app, enabling users to track their lung health trends over time. The SpiroCloud platform aggregates and analyzes data from connected SpiroHome and SpiroClinic spirometers, providing a remote respiratory disease management platform for both patients and healthcare providers. This facilitates more frequent monitoring and timely intervention for individuals with chronic respiratory illnesses.
Target Audience
The primary target audience includes patients with asthma, COPD, and cystic fibrosis, as well as healthcare providers and respiratory clinics managing these conditions.
Features
- Personal ultrasonic spirometer for accurate and reliable lung function testing at home
- Mobile app for tracking lung health trends and visualizing test results
- SpiroCloud web dashboard for remote monitoring and data analysis by healthcare providers
- Integration with hospital electronic health record (EHR) systems via SpiroClinic Pro
- Smart inhaler attachments to improve adherence and inhaler techniques (customizable, patent-pending)